Bergman AM - Search Results

1

Micro-array analysis of resistance for gemcitabine results in increased expression of ribonucleotide reductase subunits.

Smid K, Bergman AM, Eijk PP, Veerman G, van Haperen VW, van den Ijssel P, Ylstra B, Peters GJ. Smid K, et al. Among authors: bergman am. Nucleosides Nucleotides Nucleic Acids. 2006;25(9-11):1001-7. doi: 10.1080/15257770600890269. Nucleosides Nucleotides Nucleic Acids. 2006. PMID: 17065054

2

Interaction between cisplatin and gemcitabine in vitro and in vivo.

Peters GJ, Bergman AM, Ruiz van Haperen VW, Veerman G, Kuiper CM, Braakhuis BJ. Peters GJ, et al. Among authors: bergman am. Semin Oncol. 1995 Aug;22(4 Suppl 11):72-9. Semin Oncol. 1995. PMID: 7481849

3

Synergistic interaction between cisplatin and gemcitabine in ovarian and colon cancer cell lines.

Bergman AM, Ruiz van Haperen VW, Veerman G, Kuiper CM, Peters GJ. Bergman AM, et al. Adv Exp Med Biol. 1994;370:139-43. doi: 10.1007/978-1-4615-2584-4_32. Adv Exp Med Biol. 1994. PMID: 7660877 No abstract available.

4

Preclinical combination therapy with gemcitabine and mechanisms of resistance.

Peters GJ, Ruiz van Haperen VW, Bergman AM, Veerman G, Smitskamp-Wilms E, van Moorsel CJ, Kuiper CM, Braakhuis BJ. Peters GJ, et al. Among authors: bergman am. Semin Oncol. 1996 Oct;23(5 Suppl 10):16-24. Semin Oncol. 1996. PMID: 8893877 Review.

5

Combination chemotherapy studies with gemcitabine.

van Moorsel CJ, Veerman G, Bergman AM, Guechev A, Vermorken JB, Postmus PE, Peters GJ. van Moorsel CJ, et al. Among authors: bergman am. Semin Oncol. 1997 Apr;24(2 Suppl 7):S7-17-S7-23. Semin Oncol. 1997. PMID: 9194475 Review.

6

Mechanisms of synergism between gemcitabine and cisplatin.

van Moorsel CJ, Veerman G, Vermorken JB, Voorn DA, Kroep JR, Bergman AM, Pinedo HM, Peters GJ. van Moorsel CJ, et al. Among authors: bergman am. Adv Exp Med Biol. 1998;431:581-5. doi: 10.1007/978-1-4615-5381-6_112. Adv Exp Med Biol. 1998. PMID: 9598132 Clinical Trial. No abstract available.

7

Cross-resistance of the gemcitabine resistant human ovarian cancer cell line AG6000 to standard and investigational drugs.

Bergman AM, Pinedo HM, Ruiz van Haperen VW, Veerman G, Kuiper CM, Peters GJ. Bergman AM, et al. Adv Exp Med Biol. 1998;431:587-90. doi: 10.1007/978-1-4615-5381-6_113. Adv Exp Med Biol. 1998. PMID: 9598133 No abstract available.

8

Increased sensitivity to gemcitabine of P-gP and MRP overexpressing human non-small cell lung cancer cell lines.

Bergman AM, Pinedo HM, Veerman G, Kuiper CM, Peters GJ. Bergman AM, et al. Adv Exp Med Biol. 1998;431:591-4. doi: 10.1007/978-1-4615-5381-6_114. Adv Exp Med Biol. 1998. PMID: 9598134 No abstract available.

9

Differential effects of gemcitabine on nucleotide pools of 19 solid tumor cell lines.

van Moorsel CJ, Veerman G, Ruiz van Haperen VW, Bergman AM, Jensen PB, Sehested M, Peters GJ. van Moorsel CJ, et al. Among authors: bergman am. Adv Exp Med Biol. 1998;431:661-5. doi: 10.1007/978-1-4615-5381-6_128. Adv Exp Med Biol. 1998. PMID: 9598148 No abstract available.

10

Synergistic interaction between cisplatin and gemcitabine in vitro.

Bergman AM, Ruiz van Haperen VW, Veerman G, Kuiper CM, Peters GJ. Bergman AM, et al. Clin Cancer Res. 1996 Mar;2(3):521-30. Clin Cancer Res. 1996. PMID: 9816199

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

170 results

Search Page

Filters